Please try another search
For the six months ended 30 September 2020,Immunodiagnostic Systems Hldgs PLC revenues decreased 27%to £13.7M. Net loss totaled £3M vs. income of £16K.Revenues reflect Automated segment decrease of 25% to £8.2M, Manual segment decrease of 37% to £3.6M, Technologysegment decrease of 8% to £1.9M. Net loss reflectsTechnology segment loss increase of 2% to £587K.
Period Ending: | Sep 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Total Revenue | 13.7 | 20.56 | 18.79 | 20.02 |
Gross Profit | 5.26 | 10.13 | 9.42 | 8.8 |
Operating Income | -3.54 | 1.91 | 0.64 | 0.65 |
Net Income | -2.95 | 3.33 | 0.02 | 1.1 |
Period Ending: | Sep 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Total Assets | 67.8 | 73.31 | 68.7 | 65.92 |
Total Liabilities | 13.81 | 16.22 | 11.96 | 10.62 |
Total Equity | 53.99 | 57.09 | 56.74 | 55.3 |
Period Ending: | Sep 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | -0.72 | 5.54 | 2.64 | 5.78 |
Cash From Investing Activities | -1.73 | -4.66 | -1.93 | -4.43 |
Cash From Financing Activities | -0.97 | -0.94 | -0.49 | -2.02 |
Net Change in Cash | -3.41 | -0.13 | 0.43 | -0.82 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review